CORONA Remedies block deals, bulk deals, insider trading and stake changes
NSE: CORONABSE: 544644Pharmaceuticals & BiotechnologySmall Cap
CORONA Remedies Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 2025 · Issue price ₹1,062
Last close ₹2,200.60up ₹48.60 (2.26%)BSE ₹2,197.90
Share price at the NSE close on 28 Oct 2026. Previous close ₹2,152.00.
28 Oct: open ₹2,200.00, high ₹2,210.00, low ₹2,151.00
Range of traded prices from listing on 15 Dec 2025 to 28 Oct 2026
₹1,336.60Low, 23 Dec 2025₹2,292.40High, 15 Sep 2026
- Next results date: the board meets on 30 Oct 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹13,459 Cr566th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 67.62
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 18.02
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.45%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- 26.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 30.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.19
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 30,81145.0% delivered
CORONA Remedies' insiders have 16 trade disclosures on record, the latest on 19 Aug 2026. Its promoter group made no purchase or sale on the market in the 12 months to 28 Oct 2026.
Promoter and insider buying and selling
Trades made since 29 Oct 2025.CORONA Remedies promoter holding
Bought on the marketBought on the market. The value each filer stated for its purchases on the exchange, added up; gifts, transfers and pledges are not counted. A purchase filed with no value is counted under the sum, not in it. Sold on the marketSold on the market. The value each filer stated for its sales on the exchange, added up; gifts, transfers and pledges are not counted. A sale filed with no value is counted under the sum, not in it.
- Others14 purchases, 0 sales₹0.13 CrNo saleNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.₹0.13 Cr
- Promoters and promoter group: no market trade · 1 pledge filing of unclear kind
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
CORONA Remedies insider trading
Aug 2026
- Ranjanben Kirtisinh Parmar₹0.02 Cr75 sharesBought · Immediate Relative · 5 Aug 2026 · disclosed 18 Aug · held 90 before, holds 165 after
- Apurvsinh Kirtisinh Parmar₹0.01 Cr50 sharesBought · Designated Person · 5 Aug 2026 · disclosed 18 Aug · held none before, holds 50 after
- Apurvsinh Kirtisinh Parmar₹0.01 Cr50 sharesBought · Designated Person · 5 Aug 2026 · disclosed 18 Aug · held 50 before, holds 100 after
- Apurvsinh Kirtisinh Parmar₹0.01 Cr50 sharesBought · Designated Person · 5 Aug 2026 · disclosed 18 Aug · held 100 before, holds 150 after
- Kirtisinh Manoharsinh Parmar₹0.01 Cr50 sharesBought · Immediate Relative · 5 Aug 2026 · disclosed 18 Aug · held 56 before, holds 106 after
- Kirtisinh Manoharsinh Parmar₹0.01 Cr50 sharesBought · Immediate Relative · 5 Aug 2026 · disclosed 18 Aug · held 106 before, holds 156 after
- Kirtisinh Manoharsinh Parmar₹73,41135 sharesBought · Immediate Relative · 5 Aug 2026 · disclosed 18 Aug · held 156 before, holds 191 after
- Kirtisinh Manoharsinh Parmar₹12,4946 sharesBought · Immediate Relative · 5 Aug 2026 · disclosed 18 Aug · held 191 before, holds 197 after
- Kirtisinh Manoharsinh Parmar₹99,47248 sharesBought · Immediate Relative · 5 Aug 2026 · disclosed 18 Aug · held 197 before, holds 245 after
- Kirtisinh Manoharsinh Parmar₹2,0821 sharesBought · Immediate Relative · 5 Aug 2026 · disclosed 18 Aug · held 245 before, holds 246 after
- Kirtisinh Manoharsinh Parmar₹0.01 Cr50 sharesBought · Immediate Relative · 5 Aug 2026 · disclosed 18 Aug · held 246 before, holds 296 after
- Kirtisinh Manoharsinh Parmar₹4,1452 sharesBought · Immediate Relative · 5 Aug 2026 · disclosed 18 Aug · held 296 before, holds 298 after
- Kirtisinh Manoharsinh Parmar₹89,54243 sharesBought · Immediate Relative · 5 Aug 2026 · disclosed 18 Aug · held 298 before, holds 341 after
- Ranjanben Kirtisinh Parmar₹0.02 Cr90 sharesBought · Immediate Relative · 5 Aug 2026 · disclosed 18 Aug · held none before, holds 90 after
Mar 2026
- TEJAS NAVNIT KOTHARI₹0.04 Cr250 sharesBought · Promoter And Designated Person · 2 Mar 2026 · disclosed 7 Apr
- TEJAS NAVNIT KOTHARI₹0.06 Cr400 sharesPledge · Promoter And Designated Person · 2 Mar 2026 · disclosed 7 Apr
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
CORONA Remedies stake sales and purchases
All 7 disclosures on record.
Sep 2026
- SoldAnchor Partners0.15% of the company92,763 sharesholds 0.32% after10 Sep 2026 · filed under the 2% rule · Open Market
- SoldSepia Investments Limited4.06% of the company24,85,476 sharesholds 8.62% after10 Sep 2026 · filed under the 2% rule · Open Market
- SoldSage Investment Trust0.08% of the company51,641 sharesholds 0.18% after10 Sep 2026 · filed under the 2% rule · Open Market
Jun 2026
- SoldSage Investment Trust0.15% of the company90,087 sharesholds 0.26% after17 Jun 2026 · filed under the 2% rule · Open Market
- SoldSepia Investments Limited7.08% of the company43,28,943 sharesholds 12.68% after17 Jun 2026 · filed under the 2% rule · Open Market
- SoldAnchor Partners0.26% of the company1,61,861 sharesholds 0.47% after17 Jun 2026 · filed under the 2% rule · Open Market
- AcquiredInvesco Mutual Fund0.47% of the company2,89,017 sharesholds 5.06% after17 Jun 2026 · filed under the 5% rule · Open Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
CORONA Remedies block deals and bulk deals
Last 12 months, since 29 Oct 2025: 13 block deals and 14 bulk deals, ₹2,059 Cr bought and ₹2,134 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Thursday 10 Sep 20263 firms · ₹380 Cr bought · ₹510 Cr soldNet sold ₹130 Cr
- SoldSEPIA INVESTMENTS LIMITEDSold 24,85,476 at ₹2,050.324.06% of the company₹510 Cr
- BoughtSBI MUTUAL FUNDBought 15,40,000 at ₹2,050.002.52% of the company₹316 Cr
- BoughtAMUNDI FUNDS ASIA EQUITY CONCENTRATEDBought 3,12,000 at ₹2,050.000.51% of the company₹64 Cr
Wednesday 17 Jun 202618 firms · ₹1,339 Cr bought · ₹1,526 Cr soldNet sold ₹187 Cr
- SoldSEPIA INVESTMENTS LIMITEDBlock dealSold 43,28,943 at ₹1,730.007.08% of the company₹749 Cr
- SoldSEPIA INVESTMENTS LIMITEDSold 43,28,943 at ₹1,730.007.08% of the company₹749 Cr
- BoughtHDFC MUTUAL FUNDBlock dealBought 24,50,000 at ₹1,730.004.01% of the company₹424 Cr
- BoughtHDFC MUTUAL FUNDBought 23,33,333 at ₹1,730.003.82% of the company₹404 Cr
- BoughtADITYA BIRLA SUN LIFE MUTUAL FUNDBlock dealBought 4,90,000 at ₹1,730.000.80% of the company₹85 Cr
- BoughtADITYA BIRLA SUN LIFE MUTUAL FUNDBought 4,62,035 at ₹1,730.000.76% of the company₹80 Cr
- BoughtABERDEEN ASIAN SMALLER COMPANIES INVESTMENT TRUST PLCBlock dealBought 4,50,868 at ₹1,730.000.74% of the company₹78 Cr
- BoughtABERDEEN ASIAN SMALLER COMPANIES INVESTMENT TRUST PLCBought 4,50,868 at ₹1,730.000.74% of the company₹78 Cr
- BoughtINVESCO MUTUAL FUNDBlock dealBought 2,89,017 at ₹1,730.000.47% of the company₹50 Cr
- BoughtABERDEEN STANDARD SICAV I - ASIAN SMALLER COMPANIES FUNDBlock dealBought 2,74,132 at ₹1,730.000.45% of the company₹47 Cr
- SoldANCHOR PARTNERSBlock dealSold 1,61,861 at ₹1,730.000.26% of the company₹28 Cr
- BoughtKOTAK MAHINDRA MUTUAL FUNDBlock dealBought 1,61,861 at ₹1,730.000.26% of the company₹28 Cr
- BoughtINDIA ACORN ICAV - ASHOKA WHITEOAK EMERGING MARKETS EQUITY FUNDBlock dealBought 1,48,686 at ₹1,730.000.24% of the company₹26 Cr
- BoughtWHITEOAK CAPITAL MUTUAL FUNDBlock dealBought 1,45,000 at ₹1,730.000.24% of the company₹25 Cr
- BoughtABU DHABI INVESTMENT AUTHORITY - WAYBlock dealBought 39,130 at ₹1,730.000.06% of the company₹6.77 Cr
- BoughtASHOKA WHITEOAK EMERGING MARKETS EQUITY EX CHINA FUNDBlock dealBought 29,520 at ₹1,730.000.05% of the company₹5.11 Cr
- BoughtFACTORY MUTUAL INSURANCE COMPANYBlock dealBought 10,670 at ₹1,730.000.02% of the company₹1.85 Cr
- BoughtTCW WHITE OAK EMERGING MARKETS EQUITY FUNDBlock dealBought 1,920 at ₹1,730.00under 0.01% of the company₹0.33 Cr
Monday 15 Dec 20253 firms · ₹341 Cr bought · ₹98 Cr soldNet bought ₹243 Cr
- BoughtINVESCO MUTUAL FUNDBought 16,68,573 at ₹1,447.682.73% of the company₹242 Cr
- Both waysJUNOMONETA FINSOL PRIVATE LIMITEDBought 3,18,037 at ₹1,459.32Sold 3,09,284 at ₹1,460.340.52% of the companyNet +8,753 shares₹46 Cr bought
- Both waysMARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITEDBought 3,62,031 at ₹1,463.35Sold 3,64,531 at ₹1,455.180.60% of the companyNet −2,500 shares₹53 Cr bought
A bulk deal is one client trading more than half a per cent of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 27 deals on record since listing on 15 Dec 2025.